-
Product Insights
NewNet Present Value Model: Innovent Biologics Inc’s Mazdutide
Empower your strategies with our Net Present Value Model: Innovent Biologics Inc's Mazdutide report and make more profitable business decisions. Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
Product Insights
NewNet Present Value Model: HCW Biologics Inc’s HCW-9218
Empower your strategies with our Net Present Value Model: HCW Biologics Inc's HCW-9218 report and make more profitable business decisions. Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
Product Insights
NewNet Present Value Model: Theriva Biologics Inc’s VCN-01
Empower your strategies with our Net Present Value Model: Theriva Biologics Inc's VCN-01 report and make more profitable business decisions. Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
Product Insights
NewBiological Dynamics Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Biological Dynamics Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Biological Dynamics Inc (Biological Dynamics) operates as a molecular diagnostics company. The company’s proprietary lab-on-a-chip (LOC) platform, Verita utilizes AC electrokinetics (ACE) technology for isolation of nanoparticles and macromolecules from biofluids includes whole blood, plasma and serum. It also develops lung assay to support treatment response in for patients with non-small cell lung cancer. Biological Dynamics utilizes its platform...
-
Company Insights
NewBone Biologics Corp Pipeline Insight and Competitive Landscape, 2024
Empower your strategies with our Bone Biologics Corp Pipeline Insight and Competitive Landscape, 2024 report and make more profitable business decisions. Bone Biologics Corp (Bone Biologics) is a biotechnology company which develops orthobiologic products. It develops NELL-1, a recombinant human protein growth factor, which is essential for normal bone development. It offers bone graft substitutes for spine fusion. Bone Biologics also offers NELL-1/DBX fusion device, which is a single dose vial of Nell-1 recombinant protein freeze dried onto tricalcium phosphate...
-
Product Insights
NewMLM Biologics Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our MLM Biologics Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. MLM Biologics Inc (MLM Biologics) operates as a medical device company that provides optimum wound care management for patients and doctors. The company’s product includes bio-ConneKt Wound Matrix, a collagen-based wound dressing for chronic vascular ulcers, draining wounds, partial and full thickness wounds, diabetic ulcers, trauma wounds and surgical wounds. Its product is used to treat various clinical manifestation...
-
Product Insights
NewGeneral Biologicals Corp Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our General Biologicals Corp Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. General Biologicals Corp (GBC) is a medical device company that develops and manufactures diagnostics and pharmaceutical products. The company provides in-vitro diagnostic devices. GBC offers liver inspection tools such as test reagents and equipment. GBC’s products include real-time PCR kits and automated system, ELISA kits and automated system, RIA kits, automated pipetting system, antigens, antibodies, and testing and point-of-care...
-
Product Insights
NewPrecision Biologics Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Precision Biologics Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Precision Biologics Inc (PBI), a subsidiary of NantWorks LLC, is a clinical-stage biotechnology company. The company offers cancer vaccines, antigens and antibodies, pipelines, diagnostics, therapeutics, clinical trials, tumor-specific antigens, companion diagnostic programs, and diagnostic biomarker for pancreatic and colorectal cancers. It provides services such as development of pharmaceutical and diagnostic products for the early detection and treatment of cancer...
-
Product Insights
Innovations in Soft Tissue Biologics – Global Pipeline Summary
GlobalData's Medical Devices sector report, "Innovations in Soft Tissue Biologics - Global Pipeline Summary" provides comprehensive information about the Soft Tissue Biologics pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. The Soft Tissue Biologics report provides key information and data related to: Extensive coverage of the Soft Tissue Biologics under development Review details of major pipeline products which include product description, licensing and collaboration details and other developmental...
-
Innovation Ranking
Innovation Ranking – Heat Biologics Inc
NightHawk Biosciences Inc (NightHawk Biosciences) formerly Heat Biologics Inc, is a leading biotechnology company specializing in the development and commercialization of advanced medical technologies and therapies. Its major commercially available product is Anthim (obiltoxaximab), an FDA-approved monoclonal antibody specifically developed for the treatment of inhalational anthrax. Anthim has received orphan drug exclusivity, highlighting its unique status in addressing this serious medical condition. It is also approved in Europe, Canada and the UK. NightHawk Biosciences is headquartered in Durham, North Carolina,...